BRD2 antibody (AA 227-364)
-
- Target See all BRD2 Antibodies
- BRD2 (Bromodomain Containing 2 (BRD2))
-
Binding Specificity
- AA 227-364
-
Reactivity
- Human
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- This BRD2 antibody is un-conjugated
-
Application
- Western Blotting (WB), ELISA, Flow Cytometry (FACS)
- Purpose
- BRD2 Antibody
- Purification
- Purified antibody
- Immunogen
- Purified recombinant fragment of human BRD2 (AA: 227-364) expressed in E. Coli.
- Clone
- 7C1B10
- Isotype
- IgG2b
-
-
- Application Notes
-
ELISA: 1/10000
FCM: 1/200 - 1/400
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Purified antibody in PBS with 0.05 % sodium azide.
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- 4 °C,-20 °C
- Storage Comment
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
-
- Target
- BRD2 (Bromodomain Containing 2 (BRD2))
- Alternative Name
- BRD2 (BRD2 Products)
- Background
-
Description: This gene encodes a transcriptional regulator that belongs to the BET (bromodomains and extra terminal domain) family of proteins. This protein associates with transcription complexes and with acetylated chromatin during mitosis, and it selectively binds to the acetylated lysine-12 residue of histone H4 via its two bromodomains. The gene maps to the major histocompatability complex (MHC) class II region on chromosome 6p21.3, but sequence comparison suggests that the protein is not involved in the immune response. This gene has been implicated in juvenile myoclonic epilepsy, a common form of epilepsy that becomes apparent in adolescence. Multiple alternatively spliced variants have been described for this gene.
Aliases: FSH, NAT, RNF3, FSRG1, RING3, D6S113E, O27.1.1
- Molecular Weight
- 88kDa
- Gene ID
- 6046
- HGNC
- 2101
- UniProt
- P25440
- Pathways
- Chromatin Binding, SARS-CoV-2 Protein Interactome, The Global Phosphorylation Landscape of SARS-CoV-2 Infection
-